Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › PR › Yabucoa › NPI 1396813499
Lab

Laboratorio Cima INC

Laboratorio Cima INC was paid $1.50M by Medicaid between Jan 2018 and Dec 2024, across 58 billing codes. Its largest line is 84443, Thyroid stimulating hormone (TSH) — 12% of everything it billed.

33Billing provider infoLABORATORIO CIMA INC
YABUCOA, PR 00767
33aNPI1396813499assigned 11/30/2006
28Total paid$1.50M
24GClaims137,118
24DCodes billed58
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Clinical Medical Laboratory providers in Puerto Rico

Rank by total paid#79 of 777
Median peer was paid$278K
This provider vs. median5.4×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$20K$40K$60K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201826,081$197K
201920,579$150K
202011,896$123K
202119,255$270K
202219,544$282K
202319,216$223K
2024incomplete20,547$255K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
84443 Thyroid stimulating hormone (TSH) 12% 11,432 10,541 $184K
80061 Lipid panel 12% 13,913 12,914 $179K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 9.1% 3,269 2,911 $136K
80053 Comprehensive metabolic panel 8.8% 13,037 11,993 $131K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 8.4% 18,789 16,889 $126K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 5.8% 3,567 3,255 $88K
83036 Hemoglobin; glycosylated (A1C) 4.6% 7,591 7,037 $68K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 4.2% 2,406 2,185 $63K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 4.0% 5,235 2,311 $60K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 3.6% 1,057 990 $53K
81000 3.0% 14,461 13,250 $45K
86738 2.0% 2,396 2,143 $30K
46 more codes
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 1.9% 873 $28K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 1.8% 835 $27K
82607 1.5% 1,678 $23K
84439 1.5% 2,684 $22K
86703 1.3% 1,716 $19K
84153 1.3% 1,248 $19K
82043 1.3% 3,995 $19K
82274 1.2% 1,319 $18K
86328 1.2% 869 $17K
86592 1.1% 4,145 $16K
86701 1.1% 1,924 $16K
80048 Basic metabolic panel (calcium, ionized) <1% 1,852 $14K
87088 <1% 1,730 $14K
87086 Culture, bacterial; quantitative colony count, urine <1% 1,720 $12K
84436 <1% 1,763 $11K
84479 <1% 1,518 $9K
36415 Collection of venous blood by venipuncture <1% 2,860 $8K
80050 General health panel <1% 1,208 $7K
G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous <1% 727 $7K
82951 <1% 429 $5K
80074 <1% 96 $4K
82570 <1% 921 $4K
85651 <1% 924 $3K
82947 <1% 601 $2K
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 201 $2K
82952 <1% 195 $1K
85610 <1% 423 $1K
84703 <1% 178 $1K
85730 <1% 255 $1K
86803 <1% 76 $1K
82044 <1% 201 $638.89
86038 <1% 55 $541.31
82950 <1% 73 $469.31
84460 <1% 175 $430.56
84450 <1% 175 $386.72
P9604 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge <1% 144 $217.10
82575 <1% 24 $179.60
86140 <1% 27 $135.96
84550 <1% 28 $121.92
80069 <1% 14 $118.72
86886 <1% 14 $69.58
87177 <1% 13 $56.42
86901 <1% 17 $45.92
86900 <1% 17 $45.92
84156 <1% 12 $26.83
86593 0% 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCINTRON, JUAN (PRESIDENT)